WPOI-5对早期口腔癌pN0颈部区域复发风险的影响
该回顾性队列研究纳入202例cT1/2N0口腔鳞状细胞癌患者,分析临床及病理颈部阴性者孤立性区域复发的危险因素。130例接受择区性颈清扫者中98例为pN0,其中5例(5.1%)发生孤立性区域复发。孤立性区域复发的危险因素为WPOI-5(p=0.02)和未行术后放疗(p=0.04);多因素分析仅WPOI-5保持显著。
要点
- 择区性颈清扫后pN0的早期口腔鳞癌中孤立性区域复发率为5.1%。
- WPOI-5与未行术后放疗是孤立性区域复发的危险因素。
- 多因素分析中仅WPOI-5为孤立性区域复发的独立危险因素。
核心结论
- 早期口腔鳞癌病理颈部阴性者择区性颈清扫后孤立性区域复发率可超过5%。
- WPOI-5似乎是pN0病例孤立性区域复发最重要的危险因素。
- 需进一步研究以明确WPOI-5患者术后放疗的作用。
研究设计与样本
- 回顾性队列研究,纳入202例cT1/2N0口腔鳞状细胞癌患者。
主要发现
- 130例接受择区性颈清扫的患者中98例为pN0,其中5例(5.1%)发生孤立性区域复发,7例(7.1%)发生任何区域复发。
- pN0患者中孤立性区域复发的危险因素为WPOI-5(p=0.02)和未行术后放疗(p=0.04)。
- 170例pN0或cN0/x颈部患者中,孤立性区域复发的危险因素为WPOI-5和浸润深度>10 mm。
- 多因素分析中仅WPOI-5保持显著。
局限性
- 需进一步研究以明确WPOI-5患者术后放疗的作用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Regional recurrence (RR) has been reported to occur in 7%-17% of patients with oral squamous cell carcinoma (OSCC) and pathologically negative (pN0) necks. Risk factors for isolated RR, in the absence of simultaneous local recurrence, are poorly defined. Our aim was to study risk factors for isolated RR in early OSCC with clinically and pathologically negative necks. METHODS: Retrospective cohort study of 202 patients with cT1/2N0 OSCC. RESULTS: Among 130 patients undergoing elective neck dissection, 98 were pN0. Five (5.1%) developed isolated RR, and 7 (7.1%) developed any RR. Risk factors for isolated RR were worst pattern of invasion category 5 (WPOI-5) (p = 0.02), and absence of postoperative radiotherapy (PORT) (p = 0.04). Among 170 patients with pN0 or cN0/x necks, risk factors for isolated RR were WPOI-5 and depth of invasion > 10 mm. On multivariate analysis, only WPOI-5 remained significant. CONCLUSION: Isolated RR may occur in over 5% of patients with early OSCC and pathologically negative necks after elective ND. WPOI-5 would appear to be the most important risk factor for isolated RR in pN0 cases. Further work is required to define the role of PORT in patients with WPOI-5.
引用
- Hintze J, van den Berg N, Callanan D, et al. Impact of WPOI-5 on Risk of Regional Recurrence in Early Oral Cancer With pN0 Neck. Laryngoscope. 2025. PMID: 40396632. doi:10.1002/lary.32182
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。